Discovery of 2-(alpha-methylbenzylamino) pyrazines as potent Type II inhibitors of FMS.
A series of 2-(alpha-methylbenzylamino) pyrazines have shown to be potent inhibitors of the FMS tyrosine receptor kinase. Details of SAR studies, modeling and synthesis of compounds within this series are reported.